{"id":"NCT01120691","sponsor":"Novartis Pharmaceuticals","briefTitle":"Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations","officialTitle":"A 64-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Active Controlled Study to Evaluate the Effect of QVA149 (110/50 μg o.d.) vs NVA237 (50 μg o.d.) and Open-label Tiotropium (18 μg o.d.) on COPD Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-04","primaryCompletion":"2012-07","completion":"2012-07","firstPosted":"2010-05-11","resultsPosted":"2013-09-30","lastUpdate":"2013-12-02"},"enrollment":2224,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease"],"interventions":[{"type":"DRUG","name":"QVA149","otherNames":[]},{"type":"DRUG","name":"NVA237","otherNames":[]},{"type":"DRUG","name":"tiotropium","otherNames":[]},{"type":"DRUG","name":"Salbutamol/albuterol","otherNames":[]}],"arms":[{"label":"QVA149","type":"EXPERIMENTAL"},{"label":"NVA237","type":"ACTIVE_COMPARATOR"},{"label":"open-label tiotropium","type":"ACTIVE_COMPARATOR"}],"summary":"This study is designed to assess the effect of once-daily QVA149 on COPD exacerbations in patients with severe to very severe COPD.","primaryOutcome":{"measure":"Rate of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in QVA149 and NVA237 Treatment Arms During the Treatment Period.","timeFrame":"64 weeks","effectByArm":[{"arm":"QVA149","deltaMin":0.94,"sd":null},{"arm":"NVA237","deltaMin":1.07,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":342,"countries":["United States","Argentina","Austria","Canada","Colombia","Czechia","Denmark","Estonia","Finland","France","Germany","Greece","Hungary","India","Ireland","Israel","Italy","Mexico","Netherlands","Peru","Philippines","Poland","Puerto Rico","Russia","Slovakia","South Africa","Spain","United Kingdom"]},"refs":{"pmids":["24429126"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":167,"n":729},"commonTop":["Chronic obstructive pulmonary disease","Upper respiratory tract infection bacterial","Nasopharyngitis","Viral upper respiratory tract infection","Lower respiratory tract infection"]}}